Colistin Market Demand, Size & Forecast by 2034

Q: Which region dominated the colistin market in 2025?

North America dominated the market in 2025... Read more

Colistin Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Formulation [Injectables (IV or IM), Oral, Topical Formulations, and Inhalation Solutions], Indication [Human Health (Bloodstream Infections (BSI) and Sepsis Lower, Respiratory Tract Infections (LRTI), Urinary Tract Infections (UTIs), Central Nervous System Infections, Skin Infections, Cystic Fibrosis, Tracheobronchitis or VAP, Gastrointestinal Infections, and Bowel Decontamination) and Animal Health], Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Channel, and Other Distribution Channels), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)

Status : Published
Report Code : TIPRE00042707

Category : Life Sciences
No. of Pages : 371

Available Report Formats :

Colistin Market Analysis

Market growth is driven by an increase in multidrug-resistant Gram-negative infections, sustained veterinary demand in livestock and poultry farming, and regulatory shifts and policies addressing antimicrobial resistance. Advancements in inhaled colistin formulations for respiratory infections and expansion of combination therapies for multidrug-resistant infections are expected to create ample market opportunities.

Colistin Market Overview

Rising rates of multidrug-resistant bacterial infections have led to increased demand for colistin, highlighting its role as a last-line antibiotic in critical care settings. Colistin is generally used to treat severe infections caused by Gram-negative bacteria, such as Pseudomonas aeruginosa or Acinetobacter baumannii, when other antibiotics have failed. Due to the high frequency of hospital-acquired infections, hospitals and intensive care units are expected to remain the primary end users of colistin. Market growth is expected to be supported by increasing knowledge about antimicrobial resistance, a growing number of individuals being hospitalized, and improvements in healthcare infrastructure in developing regions.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Colistin Market: Strategic Insights

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the reportâ€™s content and answer all queries if you have any.

Speak to Analyst

Colistin Market Drivers and Opportunities

Market Drivers:

Increased Multidrug-Resistant Gram-Negative Infections in Human Healthcare: The rise of multidrug-resistant Gram-negative infections, including Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae, has led to increased reliance on colistin, a last-resort antibiotic, for the treatment of severe nosocomial infections such as sepsis and ventilator-associated pneumonia.
Sustained Veterinary Demand in Livestock and Poultry Farming: Colistin continues to be used off-label in poultry and swine farming for control of Gram-negative infections—such as E. coli and Salmonella—to promote animal health and production, despite the presence of increasing regulatory restrictions and concerns regarding increasing antimicrobial resistance.
Regulatory Shifts and Policies Addressing Antimicrobial Resistance: New global regulations restricting the non-therapeutic use of colistin in agriculture are reshaping the market by reducing the amount of colistin consumed in livestock. These regulations are redirecting its supply toward regulated veterinary uses and the treatment of critically important human infections caused by multidrug-resistant organisms‍‌‍‌.

Market Opportunities:

Advancements in Inhaled Colistin Formulations for Respiratory Infections: Advances in the formulations of inhaled colistin have allowed for better targeting of the lungs. These advancements make colistin more effective by providing colistin to the lung tissue with less systemic toxicity, improving compliance, and allowing for clinical trials to be conducted to expand the use of colistin in other disease states.
Expansion of Combination Therapies for Multidrug-Resistant Infections: The concurrent use of colistin with other classes of antibiotics such as meropenem, tigecycline, and fosfomycin has improved efficacy of treating the infected person, decreased the chance of developing resistance, and assisted in developing optimized regimens.
Regional Market Expansion in Asia Pacific amid Rising Antimicrobial Resistance: The increasing rate of antimicrobial resistance, growth of healthcare infrastructures, intensive livestock farming, and the growing use of last-resort antibiotics in Asia Pacific create tremendous opportunities for increasing the use of colistin for both regulated human and veterinary medicine.

Colistin Market Report Segmentation Analysis

The colistin market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in most industry reports:

By Formulation:

Oral: Colistin is administered orally primarily for veterinary purposes to control gastrointestinal infections in livestock, particularly in the production of poultry and swine.
Injectables (IV or IM): Colistin is used intravenously and subcutaneously for the treatment of severe multi-drug-resistant Gram-negative infections, particularly sepsis, pneumonia, and bloodstream infections.
Topical Formulations: Colistin is also used topically to treat localized skin, wound, and ear infections due to susceptible Gram-negative bacteria.
Inhalation Solutions: Inhalation solutions containing colistin are used to provide high concentrations of the drug directly to the lungs. They are used as a standard treatment for cystic fibrosis or chronic respiratory infections caused by Pseudomonas.

By Indication:

Human Health
Animal Health

By Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Online Channel
Other Distribution Channel

By Geography:

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Market Report Scope

Colistin Market Share Analysis by Geography

Asia Pacific is expected to grow at the fastest rate during the forecast period. The increasing prevalence of multidrug-resistant Gram-negative infections in hospitals, along with increasing demand from the animal health industry, is likely to drive the market. Emerging markets in Latin America, the Middle East, and Africa also have several untapped market opportunities.

The colistin market grows differently across regions, driven by economic growth and rising healthcare expenditure. Below is a summary of market share and trends by region:

1. North America

Market Share: Holds a significant portion of the global market
Key Drivers:
- Increased incidence of hospital-acquired multidrug-resistant Gram-negative infections, along with improvements in the healthcare environment
Trends: Increase in the number of healthcare providers participating in antimicrobial stewardship programs

2. Europe

Market Share: Substantial share due to early adoption of colistin models
Key Drivers:
- Strict implementation of antimicrobial stewardship strategies, along with the increasing number of MDR infections
Trends: Stringent Regulation for Colistin through strict prescription controls, hospital monitoring programs, and guideline-based use to minimize the occurrence of antimicrobial resistance.

3. Asia Pacific

Market Share: Fastest-growing region with an annually rising market share
Key Drivers:
- A growing population with high rates of antimicrobial resistance, coupled with ongoing improvements in healthcare systems in the region.
Trends: Increasing incidence of multidrug-resistant (MDR) Gram-negative bacteria, alongside the development of antimicrobial stewardship programs and the implementation of regulated veterinary use of colistin.

4. South and Central America

Market Share: Steadily progressing market share
Key Drivers:
- An increasing prevalence of antibiotic-resistant infections
Trends: Increasing number of hospitals using colistin to treat resistant infections

5. Middle East and Africa

Market Share: Small market share, growing at a rapid pace
Key Drivers:
- Increased prevalence of infectious diseases and ongoing improvements in healthcare access
Trends: Growing reliance on colistin for the treatment of serious hospital infections

High Market Density and Competition

Competition is strong due to the presence of established players, such as Xellia Pharmaceuticals, Livzon Pharmaceutical Group, and Zhejiang Apeloa Kangyu Pharmaceutical.

This high level of competition urges companies to stand out by offering:

Advanced security features
Competitive pricing models
Strong customer support and easy integration

Opportunities and Strategic Moves

To comply with international antimicrobial stewardship standards, producers are implementing regulations that require the responsible use of colistin in both human and veterinary medicine. Key players are increasing their production capacity for active pharmaceutical ingredients (APIs) and enhancing their distribution methods.
Pharmaceutical companies can explore combining colistin with other antibiotics to enhance therapy for multidrug-resistant infections. Manufacturers are seeing opportunities for colistin use due to rising antimicrobial resistance and the ongoing development of healthcare systems in parts of the Asia Pacific, Latin America, and Africa.

Other companies analysed during the course of research:

Meiji Seika Pharma
SNA Health Care
Fengchen Group
Sinopharm Group
Clearsynth
JSN Chemicals
HBCChem
Kaken Pharmaceutical
Hebei Veyong Pharmaceutical
Jiangsu SEL Biochem
Qingdao Qingmei Biotech
Yichang Sanxia Pharmaceutical
Tocopharm
Anhui Sinotech Industrial
Grand Health Industrial
Pfizer
Merck & Co.
Cipla
Fresenius Kabi
Teva Pharmaceutical Industries
Hikma Pharmaceuticals
Wockhardt

Colistin Market News and Recent Developments

In February 2024, PureIMS’ product Colistin Cyclops received Orphan Drug Designation from the FDA and EMA for treating cystic fibrosis (CF). This dry powder inhaler targets Pseudomonas aeruginosa infections.

In January 2024, Bio-Labs developed Colinext (colistimethate) 1 MIU to meet the growing demand for emerging antibiotics in the market. It is used to treat infections caused by Gram-negative bacteria that are highly resistant to conventional therapies.

Colistin Market Report Coverage and Deliverables

The "Colistin Market Size and Forecast (2021–2034)" report provides a detailed analysis of the market covering below areas:

Colistin Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Colistin Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST and SWOT analysis
Colistin Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Colistin Market
Detailed company profiles

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

This text is related
to segments covered.

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

This text is related
to country scope.

Frequently Asked Questions

What is the estimated value of the colistin market by 2034?

The colistin market is estimated to reach a value of US$ 510.94 million by 2034.

What is the expected CAGR of the colistin market during the forecast period?

The colistin market is estimated to register a CAGR of 4.8% during the forecast period.

Which region dominated the colistin market in 2025?

North America dominated the market in 2025.

What are the factors driving the market growth?

The increased multidrug-resistant Gram-negative infections in human healthcare, sustained veterinary demand in livestock and poultry farming, and regulatory shifts and policies addressing antimicrobial resistance are among the factors propelling market growth.

Which are the leading players operating in the colistin market?

TZF Polfa S.A., Tecoland Corporation, Fujian Lifecome Biochemistry Limited, Zhejiang Shenghua Biok Chemical Company Limited, Xellia Pharmaceuticals ApS, Shandong LuKang Pharmaceutical Co. Ltd, Livzon Pharmaceutical Group Inc., Apeloa Pharmaceutical Co. Ltd., Norma Hellas S.A, and Hebei Shengxue Dacheng Pharmaceutical Co. Ltd are among the key players operating in the market.

1. Executive Summary

1.1 Analyst Market Outlook

1.2 Market Attractiveness

2. Colistin Market Landscape

2.1 Overview

2.2 Value Chain Analysis

2.2.1 Raw Material Suppliers / Components

2.2.2 Manufacturers/ Process / Technology

2.2.3 Distribution Landscape

2.2.4 End User

2.2.5 Level of Integration

2.3 Supply Chain Analysis

2.3.1 List of Manufacturers/Suppliers

2.3.2 List of Potential Customers (Upto 50)

2.4 Porter`s Five Force Analysis

2.4.1 Bargaining Power of Suppliers: Moderate

2.4.2 Bargaining Power of Buyers: High

2.4.3 Threat of New Entrants: Moderate

2.4.4 Threat of Substitutes: High

2.4.5 Competitive Rivalry: High

2.5 PEST Analysis

2.6 Sustainability and ESG Trends

2.6.1 Sustainability Trends

2.6.2 Environmental Trends

2.6.3 Social Trends

2.6.4 Governance Trends

2.7 Regulatory Framework

2.8 Market Entry Barriers

2.8.1 Regulatory Aspect

2.8.2 Competitive Aspect

2.8.3 Reimbursement-Related Aspect

2.9 CMS Vs Colistin Base Sulphate – Manufacturing & Commercial Assessment

2.10 Global Tender Analysis

2.11 Prevalence of Key 3 Diseases, By Region, 2024

2.12 Pricing Analysis, ASPs of Key Products

2.13 Global Colistin API Market Volume (Tonnes), 2025

2.14 Pipeline Analysis of Next-Generation Polymyxins

3. Competitive Landscape

3.1 Company Benchmarking by Key Players

3.2 Market Share Analysis (%), 2025

3.3 Market Concentration

4. Colistin Market – Key Industry Dynamics

4.1 Market Drivers

4.1.1 Increased Multidrug-Resistant Gram-Negative Infections in Human Healthcare:

4.1.2 Sustained Veterinary Demand in Livestock and Poultry Farming

4.1.3 Regulatory Shifts and Policies Addressing Antimicrobial Resistance

4.2 Market Restraints

4.2.1 Limiting Clinical Adoption

4.2.2 Increased Prevalence of Colistin Resistance

4.2.3 Stringent Regulatory Policies and Bans

4.3 Market Opportunities

4.3.1 Advancements in Inhaled Colistin Formulations for Respiratory Infections

4.3.2 Expansion of Combination Therapies for Multidrug-Resistant Infections

4.3.3 Regional Market Expansion in Asia Pacific Amid Rising Antimicrobial Resistance

4.4 Future Trends

4.4.1 Advancements in Novel Formulations and Delivery Systems

4.4.2 Rise in Combination and Synergistic Therapies

4.4.3 Enhanced Antimicrobial Stewardship and Regulatory Frameworks

4.5 Impact of Drivers and Restraints

5. Colistin Market – Global Market Analysis

5.1 Colistin Market Revenue (US$ Million), 2021–2034

5.2 Colistin Market Forecast and Analysis

6. Colistin Market Revenue Analysis – Formulation

6.1 Colistin Market Forecasts and Analysis by Formulation

6.1.1 Oral

6.1.1.1 Overview

6.1.1.2 Oral: Colistin Market – Revenue, 2021–2034 (US$ Million)

6.1.2 Injectables (IV or IM)

6.1.2.1 Overview

6.1.2.2 Injectables (IV or IM): Colistin Market – Revenue, 2021–2034 (US$ Million)

6.1.3 Topical Formulations

6.1.3.1 Overview

6.1.3.2 Topical Formulations: Colistin Market – Revenue, 2021–2034 (US$ Million)

6.1.4 Inhalation Solutions

6.1.4.1 Overview

6.1.4.2 Inhalation Solutions: Colistin Market – Revenue, 2021–2034 (US$ Million)

7. Colistin Market Revenue Analysis – Indication

7.1 Colistin Market Forecasts and Analysis by Indication

7.1.1 Animal Health

7.1.1.1 Overview

7.1.1.2 Animal Health Health: Colistin Market – Revenue, 2021–2034 (US$ Million)

7.1.2 Human Health

7.1.2.1 Overview

7.1.2.2 Human Health: Colistin Market – Revenue, 2021–2034 (US$ Million)

8. Colistin Market Revenue Analysis – Distribution Channel

8.1 Colistin Market Forecasts and Analysis by Distribution Channel

8.1.1 Hospital Pharmacy

8.1.1.1 Overview

8.1.1.2 Hospital Pharmacy: Colistin Market – Revenue, 2021–2034 (US$ Million)

8.1.2 Retail Pharmacy

8.1.2.1 Overview

8.1.2.2 Retail Pharmacy: Colistin Market – Revenue, 2021–2034 (US$ Million)

8.1.3 Online Channel

8.1.3.1 Overview

8.1.3.2 Online Channel: Colistin Market – Revenue, 2021–2034 (US$ Million)

8.1.4 Other Distribution Channel

8.1.4.1 Overview

8.1.4.2 Other Distribution Channel: Colistin Market – Revenue, 2021–2034 (US$ Million)

9. Colistin Market – Geographical Analysis

9.1 North America

9.1.1 North America Colistin Market Overview

9.1.2 North America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.1.3 North America: Colistin Market – By Segmentation

9.1.3.1 Formulation

9.1.3.2 Indication

9.1.3.2.1 Human Health

9.1.3.3 Distribution Channel

9.1.4 North America: Colistin Market Breakdown by Countries

9.1.4.1 United States Market

9.1.4.1.1 United States: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.1.4.1.2 United States: Colistin Market – By Segmentation

9.1.4.1.2.1 Formulation

9.1.4.1.2.2 Indication

9.1.4.1.2.2.1 Human Health

9.1.4.1.2.3 Distribution Channel

9.1.4.2 Canada Market

9.1.4.2.1 Canada: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.1.4.2.2 Canada: Colistin Market – By Segmentation

9.1.4.2.2.1 Formulation

9.1.4.2.2.2 Indication

9.1.4.2.2.2.1 Human Health

9.1.4.2.2.3 Distribution Channel

9.1.4.3 Mexico Market

9.1.4.3.1 Mexico: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.1.4.3.2 Mexico: Colistin Market – By Segmentation

9.1.4.3.2.1 Formulation

9.1.4.3.2.2 Indication

9.1.4.3.2.2.1 Human Health

9.1.4.3.2.3 Distribution Channel

9.2 Europe

9.2.1 Europe Colistin Market Overview

9.2.2 Europe: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.3 Europe: Colistin Market – By Segmentation

9.2.3.1 Formulation

9.2.3.2 Indication

9.2.3.2.1 Human Health

9.2.3.3 Distribution Channel

9.2.4 Europe: Colistin Market Breakdown by Countries

9.2.4.1 Germany Market

9.2.4.1.1 Germany: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.1.2 Germany: Colistin Market – By Segmentation

9.2.4.1.2.1 Formulation

9.2.4.1.2.2 Indication

9.2.4.1.2.2.1 Human Health

9.2.4.1.2.3 Distribution Channel

9.2.4.2 United Kingdom Market

9.2.4.2.1 United Kingdom: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.2.2 United Kingdom: Colistin Market – By Segmentation

9.2.4.2.2.1 Formulation

9.2.4.2.2.2 Indication

9.2.4.2.2.2.1 Human Health

9.2.4.2.2.3 Distribution Channel

9.2.4.3 France Market

9.2.4.3.1 France: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.3.2 France: Colistin Market – By Segmentation

9.2.4.3.2.1 Formulation

9.2.4.3.2.2 Indication

9.2.4.3.2.2.1 Human Health

9.2.4.3.2.3 Distribution Channel

9.2.4.4 Italy Market

9.2.4.4.1 Italy: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.4.2 Italy: Colistin Market – By Segmentation

9.2.4.4.2.1 Formulation

9.2.4.4.2.2 Indication

9.2.4.4.2.2.1 Human Health

9.2.4.4.2.3 Distribution Channel

9.2.4.5 Spain Market

9.2.4.5.1 Spain: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.5.2 Spain: Colistin Market – By Segmentation

9.2.4.5.2.1 Formulation

9.2.4.5.2.2 Indication

9.2.4.5.2.2.1 Human Health

9.2.4.5.2.3 Distribution Channel

9.2.4.6 Poland Market

9.2.4.6.1 Poland: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.6.2 Poland: Colistin Market – By Segmentation

9.2.4.6.2.1 Formulation

9.2.4.6.2.2 Indication

9.2.4.6.2.2.1 Human Health

9.2.4.6.2.3 Distribution Channel

9.2.4.7 Romania Market

9.2.4.7.1 Romania: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.7.2 Romania: Colistin Market – By Segmentation

9.2.4.7.2.1 Formulation

9.2.4.7.2.2 Indication

9.2.4.7.2.2.1 Human Health

9.2.4.7.2.3 Distribution Channel

9.2.4.8 Serbia Market

9.2.4.8.1 Serbia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.8.2 Serbia: Colistin Market – By Segmentation

9.2.4.8.2.1 Formulation

9.2.4.8.2.2 Indication

9.2.4.8.2.2.1 Human Health

9.2.4.8.2.3 Distribution Channel

9.2.4.9 Bulgaria Market

9.2.4.9.1 Bulgaria: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.9.2 Bulgaria: Colistin Market – By Segmentation

9.2.4.9.2.1 Formulation

9.2.4.9.2.2 Indication

9.2.4.9.2.2.1 Human Health

9.2.4.9.2.3 Distribution Channel

9.2.4.10 Czech Republic Market

9.2.4.10.1 Czech Republic: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.10.2 Czech Republic: Colistin Market – By Segmentation

9.2.4.10.2.1 Formulation

9.2.4.10.2.2 Indication

9.2.4.10.2.2.1 Human Health

9.2.4.10.2.3 Distribution Channel

9.2.4.11 Belgium Market

9.2.4.11.1 Belgium: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.11.2 Belgium: Colistin Market – By Segmentation

9.2.4.11.2.1 Formulation

9.2.4.11.2.2 Indication

9.2.4.11.2.2.1.1 Human Health

9.2.4.11.2.3 Distribution Channel

9.2.4.12 Slovakia Market

9.2.4.12.1 Slovakia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.12.2 Slovakia: Colistin Market – By Segmentation

9.2.4.12.2.1 Formulation

9.2.4.12.2.2 Indication

9.2.4.12.2.2.1 Human Health

9.2.4.12.2.3 Distribution Channel

9.2.4.13 Ireland Market

9.2.4.13.1 Ireland: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.13.2 Ireland: Colistin Market – By Segmentation

9.2.4.13.2.1 Formulation

9.2.4.13.2.2 Indication

9.2.4.13.2.2.1 Human Health

9.2.4.13.2.3 Distribution Channel

9.2.4.14 Hungary Market

9.2.4.14.1 Hungary: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.14.2 Hungary: Colistin Market – By Segmentation

9.2.4.14.2.1 Formulation

9.2.4.14.2.2 Indication

9.2.4.14.2.2.1 Human Health

9.2.4.14.2.3 Distribution Channel

9.2.4.15 Portugal Market

9.2.4.15.1 Portugal: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.15.2 Portugal: Colistin Market – By Segmentation

9.2.4.15.2.1 Formulation

9.2.4.15.2.2 Indication

9.2.4.15.2.2.1 Human Health

9.2.4.15.2.3 Distribution Channel

9.2.4.16 Lithuania Market

9.2.4.16.1 Lithuania: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.16.2 Lithuania: Colistin Market – By Segmentation

9.2.4.16.2.1 Formulation

9.2.4.16.2.2 Indication

9.2.4.16.2.2.1 Human Health

9.2.4.16.2.3 Distribution Channel

9.2.4.17 Austria Market

9.2.4.17.1 Austria: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.17.2 Austria: Colistin Market – By Segmentation

9.2.4.17.2.1 Formulation

9.2.4.17.2.2 Indication

9.2.4.17.2.2.1 Human Health

9.2.4.17.2.3 Distribution Channel

9.2.4.18 Bosnia Market

9.2.4.18.1 Bosnia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.18.2 Bosnia: Colistin Market – By Segmentation

9.2.4.18.2.1 Formulation

9.2.4.18.2.2 Indication

9.2.4.18.2.2.1 Human Health

9.2.4.18.2.3 Distribution Channel

9.2.4.19 Latvia Market

9.2.4.19.1 Latvia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.19.2 Latvia: Colistin Market – By Segmentation

9.2.4.19.2.1 Formulation

9.2.4.19.2.2 Indication

9.2.4.19.2.2.1 Human Health

9.2.4.19.2.3 Distribution Channel

9.2.4.20 Netherlands Market

9.2.4.20.1 Netherlands: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.20.2 Netherlands: Colistin Market – By Segmentation

9.2.4.20.2.1 Formulation

9.2.4.20.2.2 Indication

9.2.4.20.2.2.1 Human Health

9.2.4.20.2.3 Distribution Channel

9.2.4.21 Greece Market

9.2.4.21.1 Greece: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.21.2 Greece: Colistin Market – By Segmentation

9.2.4.21.2.1 Formulation

9.2.4.21.2.2 Indication

9.2.4.21.2.2.1 Human Health

9.2.4.21.2.3 Distribution Channel

9.2.4.22 Rest of Europe Market

9.2.4.22.1 Rest of Europe: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.2.4.22.2 Rest of Europe: Colistin Market – By Segmentation

9.2.4.22.2.1 Formulation

9.2.4.22.2.2 Indication

9.2.4.22.2.2.1 Human Health

9.2.4.22.2.3 Distribution Channel

9.3 Asia Pacific

9.3.1 Asia Pacific Colistin Market Overview

9.3.2 Asia Pacific: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.3.3 Asia Pacific: Colistin Market – By Segmentation

9.3.3.1 Formulation

9.3.3.2 Indication

9.3.3.2.1 Human Health

9.3.3.3 Distribution Channel

9.3.4 Asia Pacific: Colistin Market Breakdown by Countries

9.3.4.1 Australia and New Zealand Market

9.3.4.1.1 Australia and New Zealand: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.3.4.1.2 Australia and New Zealand: Colistin Market – By Segmentation

9.3.4.1.2.1 Formulation

9.3.4.1.2.2 Indication

9.3.4.1.2.2.1 Human Health

9.3.4.1.2.3 Distribution Channel

9.3.4.2 Japan Market

9.3.4.2.1 Japan: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.3.4.2.2 Japan: Colistin Market – By Segmentation

9.3.4.2.2.1 Formulation

9.3.4.2.2.2 Indication

9.3.4.2.2.2.1 Human Health

9.3.4.2.2.3 Distribution Channel

9.3.4.3 Kazakhstan Market

9.3.4.3.1 Kazakhstan: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.3.4.3.2 Kazakhstan: Colistin Market – By Segmentation

9.3.4.3.2.1 Formulation

9.3.4.3.2.2 Indication

9.3.4.3.2.2.1 Human Health

9.3.4.3.2.3 Distribution Channel

9.3.4.4 Rest of APAC Market

9.3.4.4.1 Rest of APAC: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.3.4.4.2 Rest of APAC: Colistin Market – By Segmentation

9.3.4.4.2.1 Formulation

9.3.4.4.2.2 Indication

9.3.4.4.2.2.1 Human Health

9.3.4.4.2.3 Distribution Channel

9.4 Middle East and Africa

9.4.1 Middle East and Africa Colistin Market Overview

9.4.2 Middle East and Africa: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.4.3 Middle East and Africa: Colistin Market – By Segmentation

9.4.3.1 Formulation

9.4.3.2 Indication

9.4.3.2.1 Human Health

9.4.3.3 Distribution Channel

9.4.4 Middle East and Africa: Colistin Market Breakdown by Countries

9.4.4.1 Saudi Arabia Market

9.4.4.1.1 Saudi Arabia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.4.4.1.2 Saudi Arabia: Colistin Market – By Segmentation

9.4.4.1.2.1 Formulation

9.4.4.1.2.2 Indication

9.4.4.1.2.2.1 Human Health

9.4.4.1.2.3 Distribution Channel

9.4.4.2 Rest of Middle East and Africa Market

9.4.4.2.1 Rest of Middle East and Africa: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.4.4.2.2 Rest of Middle East and Africa: Colistin Market – By Segmentation

9.4.4.2.2.1 Formulation

9.4.4.2.2.2 Indication

9.4.4.2.2.2.1 Human Health

9.4.4.2.2.3 Distribution Channel

9.5 South and Central America

9.5.1 South and Central America Colistin Market Overview

9.5.2 South and Central America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.5.3 South and Central America: Colistin Market – By Segmentation

9.5.3.1 Formulation

9.5.3.2 Indication

9.5.3.2.1 Human Health

9.5.3.3 Distribution Channel

9.5.4 South and Central America: Colistin Market Breakdown by Countries

9.5.4.1 Brazil Market

9.5.4.1.1 Brazil: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.5.4.1.2 Brazil: Colistin Market – By Segmentation

9.5.4.1.2.1 Formulation

9.5.4.1.2.2 Indication

9.5.4.1.2.2.1 Human Health

9.5.4.1.2.3 Distribution Channel

9.5.4.2 Rest of South and Central America Market

9.5.4.2.1 Rest of South and Central America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

9.5.4.2.2 Rest of South and Central America: Colistin Market – By Segmentation

9.5.4.2.2.1 Formulation

9.5.4.2.2.2 Indication

9.5.4.2.2.2.1 Human Health

9.5.4.2.2.3 Distribution Channel

10. Colistin Market Industry Landscape

11. Colistin Market – Key Company Profiles

11.1 Hebei Shengxue Dacheng Pharmaceutical Co., Ltd

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Norma Hellas S.A

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Apeloa Pharmaceutical Co., Ltd.

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Livzon Pharmaceutical Group Inc

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Shandong LuKang Pharmaceutical Co., Ltd

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Xellia Pharmaceuticals ApS

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Zhejiang Shenghua Biok Chemical Company Limited

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Fujian lifecome biochemistry Limited

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Tecoland Corporation

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 TZF Polfa S.A.

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 Glossary

12.2 Research Methodology and Approach

12.2.1 Secondary Research

12.2.2 Primary Research

12.2.3 Market Estimation Approach

12.2.3.1 Supply Side Analysis

12.2.3.2 Demand Side Analysis

12.2.4 Research Assumptions and Limitations

12.2.5 Currency Conversion

12.3 About The Insight Partners

12.4 Market Intelligence Cloud

List of Tables

Table 1. List of Regulatory Bodies and Organizations

Table 2. Ease of Doing Business: Key Country Rankings

Table 3. Market Entry Barriers

Table 4. CMS Vs Colistin Base Sulphate – Manufacturing & Commercial Assessment

Table 5. Global Tender Analysis

Table 6. Prevalence of Key 3 Diseases, By Region, 2024

Table 7. Pricing Analysis, ASPs of Key Products

Table 8. Global Colistin API Market Volume (Tonnes), 2025

Table 9. Global Colistin API Market Volume (Tonnes), 2025

Table 10. Pipeline Analysis of Next-Generation Polymyxins

Table 11. Market Share Analysis (%), 2025

Table 12. Colistin Market – Revenue, 2021–2025 (US$ Million)

Table 13. Colistin Market – Revenue Forecast, 2026–2034 (US$ Million)

Table 14. Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 15. Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 16. North America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 17. North America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 18. North America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 19. North America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 20. North America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 21. North America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 22. North America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 23. North America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 24. United States: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 25. United States: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 26. United States: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 27. United States: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 28. United States: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 29. United States: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 30. United States: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 31. United States: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 32. Canada: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 33. Canada: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 34. Canada: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 35. Canada: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 36. Canada: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 37. Canada: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 38. Canada: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 39. Canada: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 40. Mexico: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 41. Mexico: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 42. Mexico: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 43. Mexico: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 44. Mexico: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 45. Mexico: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 46. Mexico: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 47. Mexico: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 48. Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 49. Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 50. Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 51. Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 52. Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 53. Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 54. Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 55. Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 56. Germany: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 57. Germany: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 58. Germany: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 59. Germany: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 60. Germany: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 61. Germany: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 62. Germany: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 63. Germany: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 64. United Kingdom: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 65. United Kingdom: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 66. United Kingdom: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 67. United Kingdom: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 68. United Kingdom: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 69. United Kingdom: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 70. United Kingdom: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 71. United Kingdom: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 72. France: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 73. France: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 74. France: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 75. France: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 76. France: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 77. France: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 78. France: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 79. France: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 80. Italy: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 81. Italy: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 82. Italy: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 83. Italy: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 84. Italy: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 85. Italy: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 86. Italy: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 87. Italy: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 88. Spain: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 89. Spain: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 90. Spain: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 91. Spain: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 92. Spain: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 93. Spain: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 94. Spain: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 95. Spain: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 96. Poland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 97. Poland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 98. Poland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 99. Poland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 100. Poland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 101. Poland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 102. Poland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 103. Poland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 104. Romania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 105. Romania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 106. Romania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 107. Romania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 108. Romania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 109. Romania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 110. Romania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 111. Romania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 112. Serbia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 113. Serbia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 114. Serbia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 115. Serbia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 116. Serbia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 117. Serbia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 118. Serbia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 119. Serbia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 120. Bulgaria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 121. Bulgaria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 122. Bulgaria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 123. Bulgaria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 124. Bulgaria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 125. Bulgaria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 126. Bulgaria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 127. Bulgaria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 128. Czech Republic: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 129. Czech Republic: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 130. Czech Republic: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 131. Czech Republic: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 132. Czech Republic: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 133. Czech Republic: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 134. Czech Republic: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 135. Czech Republic: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 136. Belgium: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 137. Belgium: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 138. Belgium: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 139. Belgium: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 140. Belgium: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 141. Belgium: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 142. Belgium: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 143. Belgium: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 144. Slovakia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 145. Slovakia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 146. Slovakia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 147. Slovakia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 148. Slovakia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 149. Slovakia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 150. Slovakia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 151. Slovakia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 152. Ireland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 153. Ireland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 154. Ireland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 155. Ireland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 156. Ireland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 157. Ireland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 158. Ireland: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 159. Ireland: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 160. Hungary: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 161. Hungary: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 162. Hungary: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 163. Hungary: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 164. Hungary: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 165. Hungary: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 166. Hungary: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 167. Hungary: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 168. Portugal: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 169. Portugal: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 170. Portugal: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 171. Portugal: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 172. Portugal: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 173. Portugal: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 174. Portugal: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 175. Portugal: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 176. Lithuania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 177. Lithuania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 178. Lithuania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 179. Lithuania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 180. Lithuania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 181. Lithuania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 182. Lithuania: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 183. Lithuania: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 184. Austria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 185. Austria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 186. Austria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 187. Austria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 188. Austria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 189. Austria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 190. Austria: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 191. Austria: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 192. Bosnia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 193. Bosnia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 194. Bosnia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 195. Bosnia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 196. Bosnia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 197. Bosnia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 198. Bosnia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 199. Bosnia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 200. Latvia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 201. Latvia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 202. Latvia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 203. Latvia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 204. Latvia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 205. Latvia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 206. Latvia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 207. Latvia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 208. Netherlands: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 209. Netherlands: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 210. Netherlands: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 211. Netherlands: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 212. Netherlands: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 213. Netherlands: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 214. Netherlands: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 215. Netherlands: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 216. Greece: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 217. Greece: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 218. Greece: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 219. Greece: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 220. Greece: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 221. Greece: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 222. Greece: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 223. Greece: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 224. Rest of Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 225. Rest of Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 226. Rest of Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 227. Rest of Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 228. Rest of Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 229. Rest of Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 230. Rest of Europe: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 231. Rest of Europe: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 232. Asia Pacific: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 233. Asia Pacific: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 234. Asia Pacific: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 235. Asia Pacific: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 236. Asia Pacific: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 237. Asia Pacific: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 238. Asia Pacific: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 239. Asia Pacific: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 240. Australia and New Zealand: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 241. Australia and New Zealand: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 242. Australia and New Zealand: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 243. Australia and New Zealand: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 244. Australia and New Zealand: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 245. Australia and New Zealand: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 246. Australia and New Zealand: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 247. Australia and New Zealand: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 248. Japan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 249. Japan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 250. Japan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 251. Japan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 252. Japan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 253. Japan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 254. Japan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 255. Japan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 256. Kazakhstan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 257. Kazakhstan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 258. Kazakhstan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 259. Kazakhstan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 260. Kazakhstan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 261. Kazakhstan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 262. Kazakhstan: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 263. Kazakhstan: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 264. Rest of APAC: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 265. Rest of APAC: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 266. Rest of APAC: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 267. Rest of APAC: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 268. Rest of APAC: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 269. Rest of APAC: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 270. Rest of APAC: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 271. Rest of APAC: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 272. Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 273. Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 274. Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 275. Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 276. Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 277. Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 278. Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 279. Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 280. Saudi Arabia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 281. Saudi Arabia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 282. Saudi Arabia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 283. Saudi Arabia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 284. Saudi Arabia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 285. Saudi Arabia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 286. Saudi Arabia: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 287. Saudi Arabia: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 288. Rest of Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 289. Rest of Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 290. Rest of Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 291. Rest of Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 292. Rest of Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 293. Rest of Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 294. Rest of Middle East and Africa: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 295. Rest of Middle East and Africa: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 296. South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 297. South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 298. South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 299. South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 300. South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 301. South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 302. South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 303. South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 304. Brazil: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 305. Brazil: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 306. Brazil: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 307. Brazil: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 308. Brazil: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 309. Brazil: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 310. Brazil: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 311. Brazil: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 312. Rest of South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Formulation

Table 313. Rest of South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Formulation

Table 314. Rest of South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Indication

Table 315. Rest of South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Indication

Table 316. Rest of South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Human Health

Table 317. Rest of South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Human Health

Table 318. Rest of South and Central America: Colistin Market – Revenue, 2021–2025 (US$ Million) – by Distribution Channel

Table 319. Rest of South and Central America: Colistin Market – Revenue Forecast, 2026–2034 (US$ Million) – by Distribution Channel

Table 320. Glossary – Colistin Market

List of Figures

Figure 1. Colistin Market Segmentation. 2

Figure 2. Colistin Market – Value Chain Analysis

Figure 3. Porter’s Five Forces Analysis

Figure 4. Pest Analysis

Figure 5. Colistin Market – Key Industry Dynamics

Figure 6. Impact Analysis of Drivers and Restraints

Figure 7. Colistin Market Revenue (US$ Million), 2021–2034

Figure 8. Colistin Market Share (%) – by Formulation (2025 and 2034)

Figure 9. Oral: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 10. Injectables (IV or IM): Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 11. Topical Formulations: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 12. Inhalation Solutions: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 13. Colistin Market Share (%) – by Indication (2025 and 2034)

Figure 14. Human Health: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 15. Human Health: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 16. Colistin Market Share (%) – by Distribution Channel (2025 and 2034)

Figure 17. Hospital Pharmacy: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 18. Retail Pharmacy: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 19. Online Channel: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 20. Other Distribution Channel: Colistin Market – Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 21. North America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 22. North America: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)

Figure 23. United States: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 24. Canada: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 25. Mexico: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 26. Europe: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 27. Europe: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)

Figure 28. Germany: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 29. United Kingdom: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 30. France: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 31. Italy: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 32. Spain: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 33. Poland: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 34. Romania: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 35. Serbia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 36. Bulgaria: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 37. Czech Republic: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 38. Belgium: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 39. Slovakia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 40. Ireland: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 41. Hungary: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 42. Portugal: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 43. Lithuania: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 44. Austria: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 45. Bosnia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 46. Latvia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 47. Netherlands: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 48. Greece: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 49. Rest of Europe: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 50. Asia Pacific: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 51. Asia Pacific: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)

Figure 52. Australia and New Zealand: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 53. Japan: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 54. Kazakhstan: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 55. Rest of APAC: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 56. Middle East and Africa: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 57. Middle East and Africa: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)

Figure 58. Saudi Arabia: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 59. Rest of Middle East and Africa: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 60. South and Central America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 61. South and Central America: Colistin Market Breakdown by Key Countries, 2025 and 2034 (%)

Figure 62. Brazil: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 63. Rest of South and Central America: Colistin Market Revenue and Forecasts, 2021–2034 (US$ Million)

Figure 64. Bottom–Up Approach and Top–Down Approach

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Please use your business email for quicker response

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.